Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 4 | 2023 | 100 | 1.380 |
Why?
|
| Orf virus | 1 | 2025 | 5 | 0.930 |
Why?
|
| Ecthyma, Contagious | 1 | 2025 | 6 | 0.930 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2025 | 13 | 0.910 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2025 | 15 | 0.900 |
Why?
|
| Soft Tissue Infections | 1 | 2025 | 91 | 0.850 |
Why?
|
| Hypersensitivity | 2 | 2023 | 196 | 0.650 |
Why?
|
| Respiratory Tract Infections | 2 | 2023 | 291 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 2555 | 0.580 |
Why?
|
| Leiomyoma | 1 | 2017 | 83 | 0.510 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 111 | 0.500 |
Why?
|
| Outpatients | 3 | 2023 | 275 | 0.470 |
Why?
|
| Progesterone | 1 | 2017 | 451 | 0.460 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 614 | 0.410 |
Why?
|
| Ascaridoidea | 1 | 2022 | 5 | 0.390 |
Why?
|
| Ascaridida Infections | 1 | 2022 | 5 | 0.390 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 32 | 0.370 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2022 | 30 | 0.370 |
Why?
|
| Myelitis | 1 | 2022 | 15 | 0.370 |
Why?
|
| Meningitis | 1 | 2022 | 100 | 0.370 |
Why?
|
| Cronobacter sakazakii | 1 | 2021 | 4 | 0.360 |
Why?
|
| Enterovirus | 1 | 2022 | 52 | 0.360 |
Why?
|
| Penicillins | 4 | 2023 | 155 | 0.360 |
Why?
|
| Enterovirus Infections | 1 | 2022 | 49 | 0.350 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2021 | 56 | 0.350 |
Why?
|
| Texas | 4 | 2025 | 3634 | 0.340 |
Why?
|
| Myositis | 1 | 2022 | 105 | 0.340 |
Why?
|
| Antimicrobial Stewardship | 1 | 2022 | 85 | 0.340 |
Why?
|
| Infant Formula | 1 | 2021 | 98 | 0.340 |
Why?
|
| Meningitis, Bacterial | 1 | 2021 | 97 | 0.330 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 248 | 0.320 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2020 | 28 | 0.320 |
Why?
|
| Child | 13 | 2025 | 25795 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 2062 | 0.310 |
Why?
|
| Milk, Human | 1 | 2022 | 308 | 0.310 |
Why?
|
| Exanthema | 1 | 2020 | 74 | 0.300 |
Why?
|
| Public Health | 1 | 2021 | 281 | 0.300 |
Why?
|
| Fever | 1 | 2020 | 310 | 0.270 |
Why?
|
| Abscess | 1 | 2019 | 140 | 0.270 |
Why?
|
| Pneumonia | 1 | 2020 | 334 | 0.250 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 571 | 0.250 |
Why?
|
| Osteomyelitis | 1 | 2019 | 213 | 0.240 |
Why?
|
| Tuberculosis | 1 | 2022 | 556 | 0.240 |
Why?
|
| Goats | 1 | 2025 | 61 | 0.230 |
Why?
|
| Sialic Acids | 1 | 2014 | 19 | 0.230 |
Why?
|
| Disease Management | 1 | 2019 | 565 | 0.220 |
Why?
|
| Electronic Health Records | 1 | 2022 | 802 | 0.220 |
Why?
|
| Sheep | 1 | 2025 | 229 | 0.220 |
Why?
|
| Influenza A Virus, H7N9 Subtype | 1 | 2014 | 30 | 0.220 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 62 | 0.220 |
Why?
|
| Humans | 17 | 2025 | 132276 | 0.200 |
Why?
|
| Infant | 5 | 2025 | 13062 | 0.200 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 451 | 0.190 |
Why?
|
| Skin | 1 | 2025 | 527 | 0.190 |
Why?
|
| Primary Health Care | 3 | 2023 | 804 | 0.180 |
Why?
|
| Pediatrics | 1 | 2020 | 1211 | 0.170 |
Why?
|
| Retrospective Studies | 5 | 2025 | 17413 | 0.170 |
Why?
|
| Child, Preschool | 4 | 2025 | 14749 | 0.160 |
Why?
|
| Brain | 1 | 2021 | 3183 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 2014 | 1049 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2014 | 823 | 0.150 |
Why?
|
| Role | 1 | 2017 | 30 | 0.140 |
Why?
|
| Female | 8 | 2025 | 70808 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 234 | 0.130 |
Why?
|
| Adolescent | 2 | 2025 | 20571 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 189 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2017 | 1080 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 540 | 0.120 |
Why?
|
| Male | 6 | 2025 | 65036 | 0.110 |
Why?
|
| Animals | 4 | 2025 | 34845 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1714 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1284 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2023 | 5173 | 0.100 |
Why?
|
| Philadelphia | 1 | 2022 | 27 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2022 | 58 | 0.090 |
Why?
|
| Streptococcus agalactiae | 1 | 2022 | 103 | 0.090 |
Why?
|
| BCG Vaccine | 1 | 2022 | 112 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2017 | 2679 | 0.090 |
Why?
|
| Disease Progression | 1 | 2017 | 2230 | 0.090 |
Why?
|
| Skin Tests | 1 | 2021 | 80 | 0.080 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 38 | 0.080 |
Why?
|
| Myalgia | 1 | 2020 | 11 | 0.080 |
Why?
|
| Disease Vectors | 1 | 2020 | 22 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1884 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2511 | 0.080 |
Why?
|
| Cephalosporins | 1 | 2020 | 139 | 0.080 |
Why?
|
| Feedback | 1 | 2020 | 167 | 0.080 |
Why?
|
| Doxycycline | 1 | 2020 | 121 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 329 | 0.080 |
Why?
|
| Hospitals | 1 | 2022 | 439 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2022 | 8548 | 0.070 |
Why?
|
| Vaccination | 1 | 2022 | 1018 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3414 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2021 | 701 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1963 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 767 | 0.050 |
Why?
|
| Chemokines | 1 | 2014 | 130 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 13036 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 1902 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 1050 | 0.050 |
Why?
|
| Virus Replication | 1 | 2014 | 636 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 1365 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 6243 | 0.040 |
Why?
|
| Lung | 1 | 2014 | 1556 | 0.030 |
Why?
|
| Mice | 1 | 2014 | 18506 | 0.020 |
Why?
|